Vistisen, D., Andersen, G. S.
, Hulman, A., McGurnaghan, S. J., Colhoun, H. M., Henriksen, J. E.
, Thomsen, R. W., Persson, F., Rossing, P. & Jørgensen, M. E. (2021).
A validated prediction model for end-stage kidney disease in type 1 diabetes.
Diabetes Care,
44(4), 901-907.
https://doi.org/10.2337/dc20-2586
Vistisen, D., Andersen, G. S.
, Hulman, A., McGurnaghan, S. J., Colhoun, H. M., Henriksen, J. E.
, Thomsen, R. W., Persson, F.
, Rossing, P. & Jørgensen, M. E. (2021).
Response to Comment on Vistisen et al. A validated prediction model for endstage kidney disease in type 1 diabetes. Diabetes care 2021;44:901–907.
Diabetes Care,
44(6), e140-e141.
https://doi.org/10.2337/dci21-0010
Viuff, M. H., Stochholm, K., Lin, A.
, Berglund, A., Juul, S. & Gravholt, C. H. (2021).
Cancer occurrence in Turner syndrome and the effect of sex hormone substitution therapy.
European Journal of Endocrinology,
184(1), 79-88.
https://doi.org/10.1530/EJE-20-0702
Viuff, M. H., Stochholm, K., Grønbaek, H., Berglund, A., Juul, S. & Gravholt, C. H. (2021).
Increased occurrence of liver and gastrointestinal diseases and anaemia in women with Turner syndrome - a nationwide cohort study.
Alimentary Pharmacology and Therapeutics,
53(7), 821-829.
https://doi.org/10.1111/apt.16277
von Herrath, M., Bain, S. C., Bode, B., Clausen, J. O., Coppieters, K., Gaysina, L., Gumprecht, J.
, Hansen, T. K., Mathieu, C., Morales, C., Mosenzon, O., Segel, S., Tsoukas, G., Pieber, T. R. & Anti-IL-21–liraglutide Study Group investigators and contributors (2021).
Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial.
The Lancet Diabetes & Endocrinology,
9(4), 212-224.
https://doi.org/10.1016/S2213-8587(21)00019-X
Winkel, P., Hilden, J., Jakobsen, J. C., Lindschou, J., Jensen, G. B., Kjøller, E., Sajadieh, A., Kastrup, J., Kolmos, H. J., Larsson, A., Ärnlöv, J.
, Bjerre, M. & Gluud, C. (2021).
A screening method to spot biomarkers that may warn of serious events in a chronic disease - illustrated by cardiological CLARICOR trial data.
Clinical Chemistry and Laboratory Medicine,
59(11), 1852-1860.
https://doi.org/10.1515/cclm-2021-0333
Xiang, X., Zhao, X., Pan, X., Dong, Z., Yu, J., Li, S., Liang, X., Han, P., Qu, K.
, Jensen, J. B., Farup, J., Wang, F., Petersen, T. S., Bolund, L., Teng, H.
, Lin, L. & Luo, Y. (2021).
Efficient correction of Duchenne muscular dystrophy mutations by SpCas9 and dual gRNAs.
Molecular Therapy - Nucleic Acids,
24, 403-415.
https://doi.org/10.1016/j.omtn.2021.03.005
Xiang, X., Corsi, G. I., Anthon, C., Qu, K., Pan, X., Liang, X., Han, P., Dong, Z., Liu, L., Zhong, J., Ma, T., Wang, J., Zhang, X., Jiang, H., Xu, F., Liu, X., Xu, X., Wang, J., Yang, H.
... Luo, Y. (2021).
Enhancing CRISPR-Cas9 gRNA efficiency prediction by data integration and deep learning.
Nature Communications,
12(1), Article 3238.
https://doi.org/10.1038/s41467-021-23576-0
Zhang, C. D., Li, D., Kaur, R. J.
, Ebbehoj, A., Singh, S., Atkinson, E. J., Achenbach, S. J., Young, W. F., Arlt, W., Rocca, W. A. & Bancos, I. (2021).
Cardiometabolic Outcomes and Mortality in Patients with Adrenal Adenomas in a Population-based Setting: A Population-Based Cohort Study.
The Journal of clinical endocrinology and metabolism,
106(11), 3320-3330.
https://doi.org/10.1210/clinem/dgab468
Zhang, C., Li, C., Yang, L., Leng, L., Jovic, D., Wang, J., Fang, F., Li, G., Zhao, D., Li, X.
, Lin, L., Luo, Y., Bolund, L., Huang, J., Lin, G. & Xu, F. (2021).
The Dynamic Changes of Transcription Factors During the Development Processes of Human Biparental and Uniparental Embryos.
Frontiers in Cell and Developmental Biology,
9, Article 709498.
https://doi.org/10.3389/fcell.2021.709498